Day One Biopharmaceuticals's total assets for Q4 2024 were $582.79M, a decrease of -3.00% from the previous quarter. DAWN total liabilities were $80.04M for the fiscal quarter, a 76.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.